Radiotherapy
-
Proton Beam Therapy
Jason LesterEuropean Oncology & Haematology, 2018;14(2):82–3 DOI: https://doi.org/10.17925/EOH.2018.14.2.82 -
To Hyperfractionate or not to Hyperfractionate – Is it Really a Question?
Jesper Grau Eriksen, Marco C MerlanoEuropean Oncology & Haematology, 2016;12(1):19–20 DOI: https://doi.org/10.17925/EOH.2016.12.01.19 -
Future of Radiotherapy Delivery in Rectal Cancer— European and US Approaches
Jordan A Torok, Brian G Czito, Christopher G Willett, Manisha PaltaOncology & Hematology Review, 2014;10(2):139–43 DOI: https://doi.org/10.17925/OHR.2014.10.2.139 -
Mucositis—Supportive Care During Radiotherapy or Chemoradiotherapy of Head and Neck Cancer
Eli Sapir, Avraham EisbruchOncology & Hematology Review, 2015;11(1):50–2 DOI: https://doi.org/10.17925/OHR.2015.11.01.50 -
Head and Neck Cancer Highlights of ESMO Congress 2014
Panagiota Economopoulou, Giannis Kotsantis, George Kavourakis, Amanda PsyrriEuropean Oncology & Haematology, 2014;10(2):96–7 DOI: https://doi.org/10.17925/EOH.2014.10.2.96 -
Atlas-based Auto-contouring – Balancing Accuracy with Efficiency in OnQ rts®
Susan Barley, Clare Antoine, Gareth Webster, Marie Tiffany, Navinah Nundlall, Rosemary Simmons, Andrew HartleyEuropean Oncology & Haematology, 2014;10(2):98–101 DOI: https://doi.org/10.17925/EOH.2014.10.2.98